Recruiting

Observational Study

Sponsor:

The University of Texas at Arlington

Code:

NCT06857877

Conditions

Aging

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Study Details

Brief summary:

The goal of this observational study is to learn about the mechanisms causing functional decline with age, using magnetic resonance imaging, exercise science, integrative physiology, neuroscience, and remote monitoring.

Specific aims include:

Aim 1: Advance knowledge of the biology of aging and its impact on the prevention, progression, and prognosis of disease and disability.

Aim 2: Determine the effects of personal and societal factors on aging.

Aim 3: Examine the influence of racial/ethnic and sex differences on the biology of aging and its impact on the prevention, progression, and prognosis of disease and disability.

Conditions

Aging

Study ID

NCT06857877

Start date

Sep 1, 2024

Status verified date

Apr, 2026

Completion date

Dec 31, 2030

Anticipated

Primary completion date

Dec 31, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

Phase 1: Young healthy men and women between 18 - 30 years of age, and older men and women between 50 - 80 years of age.

Phase 2: Men and women living in Tarrant County, Texas, between 50 - 85 years of age. In addition, the investigators will study up to 120 younger men and women, between 18-30 years of age, equally divided by race/ethnicity (same as above) and sex, to serve as reference controls.

Exclusion Criteria:

Phase 1: Clinical diagnosis of dementia; major depression (diagnosed by a physician), visual or auditory impairments that preclude neuropsychological testing or otherwise jeopardize the health and wellbeing of the participant during testing, non-ambulatory status (i.e. less than 10 m without mobility aid), shortness of breath while performing normal activities of daily living (walking through grocery store), body mass index greater than 45 kg/m2, heart failure or cardiomyopathy, acute coronary syndrome, primary valvular heart disease, severe gait disorder due to musculoskeletal disease or neurological motor deficit (e.g. severe osteoarthritis, lower limb amputation, Parkinson's disease, major stroke with motor sequelae); daily consumption of more than two alcoholic beverages; current treatment for cancer, and estimated life expectancy less than 4 years. Inclusion/exclusion will be verified using the demographics and medical history.

Phase 2: Clinical diagnosis of dementia; major depression (diagnosed by a physician), visual or auditory impairments that preclude neuropsychological testing or otherwise jeopardize the health and wellbeing of the participant during testing, non-ambulatory status (i.e. less than 10 m without mobility aid), shortness of breath while performing normal activities of daily living (walking through grocery store), body mass index greater than 45 kg/m2, heart failure or cardiomyopathy, acute coronary syndrome, primary valvular heart disease, severe gait disorder due to musculoskeletal disease or neurological motor deficit (e.g. severe osteoarthritis, lower limb amputation, Parkinson's disease, major stroke with motor sequelae), daily consumption of more than two alcoholic beverages; current treatment for cancer, and estimated life expectancy less than 4 years. Inclusion/exclusion will be verified using the demographics and medical history.

Study Design

Enrollment

770 participants

Anticipated

Interventions and Outcome Measures

Arms

Older Adults

Primary outcome measure

  • Sense of Smell [ Time Frame: Baseline ]
  • Blood Pressure [ Time Frame: Baseline ]
  • Street Address [ Time Frame: Baseline ]
  • Ankle Brachial Index [ Time Frame: Baseline ]
  • Pulse Wave Velocity [ Time Frame: Baseline ]
  • Flow- mediated dilation [ Time Frame: Baseline ]
  • Steps taken [ Time Frame: Baseline ]
  • Sedentary Time [ Time Frame: Baseline ]
  • Sleep [ Time Frame: Baseline ]
  • Medical History Questionnaire [ Time Frame: Baseline ]
  • Complete blood count [ Time Frame: Baseline ]
  • Functional Mobility [ Time Frame: Baseline ]
  • Cognitive Function [ Time Frame: Baseline ]
  • Lower extremity function [ Time Frame: Baseline ]
  • Grip strength [ Time Frame: Baseline ]
  • Bone Density [ Time Frame: Baseline ]
  • Interstitial glucose [ Time Frame: Baseline ]
  • Body Composition [ Time Frame: Baseline ]
  • Ambulatory blood pressure [ Time Frame: Baseline ]
  • Exercise Capacity [ Time Frame: Baseline ]
  • Blood lipids [ Time Frame: Baseline ]
  • Metabolic Panel (blood) [ Time Frame: Baseline ]
  • Apolipoprotein A [ Time Frame: Baseline ]
  • Apolipoprotein B [ Time Frame: Baseline ]
  • Lipoprotein A [ Time Frame: Baseline ]
  • Blood checmistry panel [ Time Frame: Baseline ]
  • HbA1C (blood) [ Time Frame: Baseline ]
  • High sensitivity C reactive protein (blood) [ Time Frame: Baseline ]
  • Genetic testing [ Time Frame: Baseline ]

Central Contacts and Locations

Central contacts

Locations

University of Texas Arlington

Recruiting

Arlington, Texas, United States, 76019

Contacts

Principal Investigator:

Michael Nelson, PhD

More Information

Sponsor

The University of Texas at Arlington

Last update posted

Apr 23, 2026

Last verified

Apr, 2026

Keywords

  • Aging
  • MRI
  • Cognitive Function
  • Exercise Science
  • Remote Monitoring

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by The University of Texas at Arlington on 2026-04-23.